5EMY
Human Pancreatic Alpha-Amylase in complex with the mechanism based inactivator glucosyl epi-cyclophellitol
Summary for 5EMY
Entry DOI | 10.2210/pdb5emy/pdb |
Related | 1CPU 4W93 4X9Y |
Descriptor | Pancreatic alpha-amylase, (1R,2R,3S,5R,6S)-2,3,5-trihydroxy-6-(hydroxymethyl)cyclohexyl alpha-D-glucopyranoside, CHLORIDE ION, ... (5 entities in total) |
Functional Keywords | amylase, diabetes, obesity, glucosyl hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 56347.16 |
Authors | Caner, S.,Brayer, G.D. (deposition date: 2015-11-06, release date: 2016-07-06, Last modification date: 2024-10-23) |
Primary citation | Caner, S.,Zhang, X.,Jiang, J.,Chen, H.M.,Nguyen, N.T.,Overkleeft, H.,Brayer, G.D.,Withers, S.G. Glucosyl epi-cyclophellitol allows mechanism-based inactivation and structural analysis of human pancreatic alpha-amylase. Febs Lett., 590:1143-1151, 2016 Cited by PubMed Abstract: As part of a search for selective, mechanism-based covalent inhibitors of human pancreatic α-amylase we describe the chemoenzymatic synthesis of the disaccharide analog α-glucosyl epi-cyclophellitol, demonstrate its stoichiometric reaction with human pancreatic α-amylase and evaluate the time dependence of its inhibition. X-ray crystallographic analysis of the covalent derivative so formed confirms its reaction at the active site with formation of a covalent bond to the catalytic nucleophile D197. The structure illuminates the interactions with the active site and confirms OH4' on the nonreducing end sugar as a good site for attachment of fluorescent tags in generating probes for localization and quantitation of amylase in vivo. PubMed: 27000970DOI: 10.1002/1873-3468.12143 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.231 Å) |
Structure validation
Download full validation report